By Sarah Welsh
by Sarah Welsh
After a two-year hiatus, the Large Hadron Collider at the European Organization for Nuclear Research, or CERN, is gearing up for its second run. The LHC enabled the 2012 discovery of the Higgs boson, which gives mass to all particles, but the world’s most complicated scientific apparatus is far from finished
By Julie McWilliams
Aspiring journalist Brennan Cusack set off on a solo cross-country trek last summer to get an insider’s look and to research four instances where environmental and economic interests were at odds.
Timothy Rebbeck of the Perelman School of Medicine is quoted about varying BRCA1 or BRCA2 mutations and how this affect
In a study involving more than 31,000 women with cancer-causing mutations in the BRCA1 or BRCA2 genes, researchers at the Basser Center for BRCA, the Abramson Cancer Center, and the Perelman School of Medicine at the University of Pennsylvania, identified mutations that are associated with significantly different risks of breast and ovarian cancers.
Why do some people learn a new skill right away, while others only gradually improve? Whatever else may be different about their lives, something must be happening in their brains that captures this variation.
Media Contact:Peter Iglinski | email@example.com | 585-273-4726April 6, 2015
Therapeutic agents intended to reduce dental plaque and prevent tooth decay are often removed by saliva and the act of swallowing before they can take effect. But a team of researchers has developed a way to keep the drugs from being washed away.
Where water and oil meet, a two-dimensional world exists. This interface presents a potentially useful set of properties for chemists and engineers, but getting anything more complex than a soap molecule to stay there and behave predictably remains a challenge.
Odds of Reversing ICU Patients' Prior Preferences to Forgo Life-Sustaining Therapies Vary Widely Across the U.S., according to Penn Study
Intensive care units across the United States vary widely in how they manage the care of patients who have set preexisting limits on life-sustaining therapies, such as authorizing do-not-resuscitate (DNR) orders and prohibiting interventions such as feeding tubes or dialysis, according to new research from the Perelman School of Medicine at the University of Pennsylvania. Their work is published in the current issue of JAMA Internal Medicine.